AbbVie vs Newton
Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
About
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
AI phone platform for dental practices handling patient scheduling, insurance verification, and reactivation campaigns; $3.8M seed from YC serving DSOs competing with Weave and NexHealth.
About
Newton is an AI-powered phone and patient communication platform for dental practices and dental service organizations (DSOs) — deploying AI voice agents that handle inbound patient calls (appointment scheduling, insurance verification questions, appointment reminders) and outbound patient reactivation campaigns that identify and contact overdue patients, automating the front-desk phone work that consumes significant staff time at dental offices. Founded in 2023 in San Francisco and a Y Combinator W24 graduate, Newton raised $3.8 million in seed funding in October 2025 from Y Combinator, Twenty Two Ventures, Transpose Platform, and Phosphor Capital.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.